In a drug utilization review (DUR), which of the following aspects is NOT reviewed?

In a drug utilization review (DUR), the primary focus is on assessing various factors that contribute to the safe and efficient use of medications by patients. DUR typically involves reviewing drug interactions, considering patient allergies, and analyzing medication therapy management to ensure that prescribed therapies are appropriate and safe for the patient.

The aspect that is not a primary focus of DUR is compliance with prescription labeling. While ensuring that patients understand the labeling is important in medication management, compliance with labeling specifically pertains more to patient behavior and understanding rather than the clinical criteria that DUR reviews. DUR is centered on the clinical implications of medication use, evaluating whether the medication regimens are appropriate given the patient's health status, medications, and history.

In summary, DUR encompasses checks that help prevent harmful drug interactions and ensure that patient allergies are considered as part of the medication regimen. However, compliance with prescription labeling does not align closely with the objectives of DUR, which aims to review medication safety and efficacy rather than patient adherence to labeling instructions.